|
KMID : 0620920070390020213
|
|
Experimental & Molecular Medicine
2007 Volume.39 No. 2 p.213 ~ p.221
|
|
|
Trichostatin A-mediated upregulation of p21WAF1 contributes to osteoclast apoptosis
|
|
Yi Tac-Ghee
Baek Jeong-Hwa
Kim Hye-Jin
Choi Mi-Hye
Seo Sang-Beom
Ryoo Hyun-Mo
Kim Gwan-Shik
Woo Kyung-Mi
|
|
|
Abstract
|
|
|
|
Histone deacetylase inhibitors (HDIs), a new class of anti-cancer agents, have been reported to suppress formation of osteoclast precursors and their fusion into multinucleated cells. However, little is known about the effect of HDIs on mature osteoclasts, which may have significance for their therapeutic use. Here, we demonstrate a novel action of HDIs on osteoclast apoptosis. Primary multinucleated mature osteoclasts were prepared from mouse bone marrow cells. Treatment of osteoclasts with the HDI trichostatin A (TSA) caused apoptosis, as confirmed by annexin V staining and caspase activation. TSA caused the upregulation of p21WAF1 in osteoclasts. To understand the role of p21WAF1 upregulation in TSA-treated osteoclasts, shRNA against p21WAF1-containing lentivirus was introduced into osteoclasts. The suppression of p21WAF1 decreased TSA-directed osteoclast apoptosis. Collectively, our results provide evidence that TSA causes osteoclast apoptosis, which involves, in part, TSA-induced upregulation of p21WAF1, and strongly supports HDIs as potential therapeutic agents for excessive bone resorption.
|
|
|
KEYWORD
|
|
|
apoptosis, CDKN1A protein, mouse, cyclin-dependent kinase inhibitor p21, histone deacetylases, osteoclasts, RNA interference, trichostatin A
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|
|